Radiation Dose-Volume Effects of Optic Nerves and Chiasm

International Journal of Radiation Oncology Biology Physics

Volumn 76, Issue 3 SUPPL., 2010, Pages

  Mayo, Charles ^a   Martel, Mary K ^b   Marks, Lawrence B ^c   Flickinger, John ^d   Nam, Jiho ^c   Kirkpatrick, John ^e  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^d PRESBYTERIAN UNIVERSITY HOSPITAL   (United States)

^e DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Chiasm; Nerve; Optic; Radiotherapy; Tolerance

Indexed keywords

CHIASM; DOSE-VOLUME; NERVE; OPTIC NERVE; RADIATION DOSE; RADIATION TOLERANCES; RADIATION TOXICITY; RADIOSURGERY;

EYE PROTECTION; RADIOTHERAPY; TOXICITY;

RADIATION EFFECTS;

ARTICLE; CHORDOMA; CRANIOPHARYNGIOMA; DOSIMETRY; ESTHESIONEUROBLASTOMA; HUMAN; HYPOPHYSIS ADENOMA; INTENSITY MODULATED RADIATION THERAPY; MATHEMATICAL MODEL; MENINGIOMA; OPTIC CHIASM; OPTIC NERVE; OPTIC NERVE INJURY; ORGAN SIZE; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RADIATION DOSE; RADIATION DOSE FRACTIONATION; RADIATION HAZARD; RADIATION INJURY; RADIOSURGERY;

AGE FACTORS; HUMANS; MAXIMUM TOLERATED DOSE; MODELS, BIOLOGICAL; OPTIC CHIASM; OPTIC NERVE; RADIATION DOSAGE; RADIATION INJURIES; RADIATION TOLERANCE; RADIOSURGERY; RADIOTHERAPY; VISION DISORDERS;

EID: 76449105282     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2009.07.1753     Document Type: Article

References (48)

1. Lessell S. Friendly fire: Neurogenic visual loss from radiation therapy. J Neuroophthalmol 24 (2004) 243-250
2. Danesh-Meyer H.V. Radiation-induced optic neuropathy. J Clin Neurosci 15 (2008) 95-100
3. Gordon K.B., Char D.H., and Sagerman R.H. Late effects of radiation on the eye and ocular adnexa. Int J Radiat Oncol Biol Phys 31 (1995) 1123-1139
4. Parsons J.T., Bova F.J., Fitzgerald C.R., et al. Radiation optic neuropathy after megavoltage external-beam irradiation: Analysis of time-dose factors. Int J Radiat Oncol Biol Phys 30 (1994) 755-763
5. Rubin P., Constine L.S., Fajardo L.F., et al. for the RTOG Late Effects Working Group. Overview: Late Effects of Normal Tissues (LENT) scoring system. Int J Radiat Oncol Biol Phys 31 (1995) 1041-1042
6. Pavy J.J., Denekamp J., Letschert J., et al. EORTC Late Effects Working Group. Late Effects toxicity scoring: the SOMA scale. Int J Radiat Oncol Biol Phys 31 (1995) 1043-1047
7. van den Bergh A.C., Dullaart R.P., Hoving M.A., et al. Radiation optic neuropathy after external beam radiation therapy for acromegaly. Radiother Oncol 68 (2003) 95-100
8. Hudgins P.A., Newman N.J., Dillon W.P., et al. Radiation-induced optic neuropathy: Characteristic appearances on gadolinium-enhanced MR. AJNR Am J Neuroradiol 13 (1992) 235-238
9. Kline L.B., Kim J.Y., and Ceballos R. Radiation optic neuropathy. Ophthalmology 92 (1985) 1118-1126
10. Celesia G.G., and DeMarco Jr. P.J. Anatomy and physiology of the visual system. J Clin Neurophysiol 11 (1994) 482-492
11. Netter F.H., and Hansen J.T. Atlas of Human Anatomy. 4th ed (2006), WB Saunders, Philadelphia
12. Duus P. Topical Diagnosis in Neurology: Anatomy, Physiology, Signs, Symptoms. 3rd rev (1998), Thieme, Stuttgart
13. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
14. Martel M.K., Sandler H.M., Cornblath W.T., et al. Dose-volume complication analysis for visual pathway structures of patients with advanced paranasal sinus tumors. Int J Radiat Oncol Biol Phys 38 (1997) 273-284
15. Jiang G.L., Tucker S.L., Guttenberger R., et al. Radiation-induced injury to the visual pathway. Radiother Oncol 30 (1994) 17-25
16. Hoppe B.S., Nelson C.J., Gomez D.R., et al. Unresectable carcinoma of the paranasal sinuses: Outcomes and toxicities. Int J Radiat Oncol Biol Phys 72 (2008) 763-769
17. Daly M.E., Chen A.M., Bucci M.K., et al. Intensity-modulated radiation therapy for malignancies of the nasal cavity and paranasal sinuses. Int J Radiat Oncol Biol Phys 67 (2007) 151-157
18. Mackley H.B., Reddy C.A., Lee S.Y., et al. Intensity-modulated radiotherapy for pituitary adenomas: The preliminary report of the Cleveland Clinic experience. Int J Radiat Oncol Biol Phys 67 (2007) 232-239
19. Aristizabal S., Caldwell W.L., and Avila J. The relationship of time-dose fractionation factors to complications in the treatment of pituitary tumors by irradiation. Int J Radiat Oncol Biol Phys 2 (1977) 667-673
20. Bhandare N., Monroe A.T., Morris C.G., et al. Does altered fractionation influence the risk of radiation-induced optic neuropathy?. Int J Radiat Oncol Biol Phys 62 (2005) 1070-1077
21. Hoppe B.S., Stegman L.D., Zelefsky M.J., et al. Treatment of nasal cavity and paranasal sinus cancer with modern radiotherapy techniques in the postoperative setting-The MSKCC experience. Int J Radiat Oncol Biol Phys 67 (2007) 691-702
22. Vatnitsky S., Moyers M., Miller D., et al. Proton dosimetry intercomparison based on the ICRU report 59 protocol. Radiother Oncol 51 (1999) 273-279
23. Newhauser W.D., Myers K.D., Rosenthal S.J., et al. Proton beam dosimetry for radiosurgery: Implementation of the ICRU Report 59 at the Harvard Cyclotron Laboratory. Phys Med Biol 47 (2002) 1369-1389
24. International Commission on Radiation Units and Measurements. Report 78: Prescribing, recording and reporting proton-beam therapy. J ICRU 7 (2007) 49-81
25. Wenkel E., Thornton A.F., Finkelstein D., et al. Benign meningioma: partially resected, biopsied, and recurrent intracranial tumors treated with combined proton and photon radiotherapy. Int J Radiat Oncol Biol Phys 48 (2000) 1363-1370
26. Noel G., Habrand J.L., Mammar H., et al. Combination of photon and proton radiation therapy for chordomas and chondrosarcomas of the skull base: The Centre de Protontherapie D'Orsay experience. Int J Radiat Oncol Biol Phys 51 (2001) 392-398
27. Weber D.C., Rutz H.P., Pedroni E.S., et al. Results of spot-scanning proton radiation therapy for chordoma and chondrosarcoma of the skull base: The Paul Scherrer Institut experience. Int J Radiat Oncol Biol Phys 63 (2005) 401-409
28. Nishimura H., Ogino T., Kawashima M., et al. Proton-beam therapy for olfactory neuroblastoma. Int J Radiat Oncol Biol Phys 68 (2007) 758-762
29. Schulz-Ertner D., Karger C.P., Feuerhake A., et al. Effectiveness of carbon ion radiotherapy in the treatment of skull-base chordomas. Int J Radiat Oncol Biol Phys 68 (2007) 449-457
30. Tishler R.B., Loeffler J.S., Lunsford L.D., et al. Tolerance of cranial nerves of the cavernous sinus to radiosurgery. Int J Radiat Oncol Biol Phys 27 (1993) 215-221
31. Stafford S.L., Pollock B.E., Leavitt J.A., et al. A study on the radiation tolerance of the optic nerves and chiasm after stereotactic radiosurgery. Int J Radiat Oncol Biol Phys 55 (2003) 1177-1181
32. Pollock B.E., Cochran J., Natt N., et al. Gamma knife radiosurgery for patients with nonfunctioning pituitary adenomas: Results from a 15-year experience. Int J Radiat Oncol Biol Phys 70 (2008) 1325-1329
33. Leber K.A., Bergloff J., and Pendl G. Dose-response tolerance of the visual pathways and cranial nerves of the cavernous sinus to stereotactic radiosurgery. J Neurosurg 88 (1998) 43-50
34. Flickinger J.C., Deutsch M., and Lunsford L.D. Repeat megavoltage irradiation of pituitary and suprasellar tumors. Int J Radiat Oncol Biol Phys 17 (1989) 171-175
35. Burman C., Kutcher G.J., Emami B., et al. Fitting of normal tissue tolerance data to an analytic function. Int J Radiat Oncol Biol Phys 21 (1991) 123-135
36. Brizel D.M., Light K., Zhou S.M., et al. Conformal radiation therapy treatment planning reduces the dose to the optic structures for patients with tumors of the paranasal sinuses. Radiother Oncol 51 (1999) 215-218
37. Flickinger J.C., Kondziolka D., and Lunsford L.D. Radiobiological analysis of tissue responses following radiosurgery. Technol Cancer Res Treat 2 (2003) 87-92
38. Kirkpatrick J.P., Meyer J.J., and Marks L.B. The linear-quadratic model is inappropriate to model high dose per fraction effects in radiosurgery. Semin Radiat Oncol 18 (2008) 240-243
39. Flickinger J.C., Lunsford L.D., Singer J., et al. Megavoltage external beam irradiation of craniopharyngiomas: Analysis of tumor control and morbidity. Int J Radiat Oncol Biol Phys 19 (1990) 117-122
40. Goldsmith B.J., Rosenthal S.A., Wara W.M., et al. Optic neuropathy after irradiation of meningioma. Radiology 185 (1992) 71-76
41. Shrieve D.C., Hazard L., Boucher K., et al. Dose fractionation in stereotactic radiotherapy for parasellar meningiomas: Radiobiological considerations of efficacy and optic nerve tolerance. J Neurosurg 101 Suppl. 3 (2004) 390-395
42. Finger P.T. Anti-VEGF bevacizumab (Avastin) for radiation optic neuropathy. Am J Ophthalmol 143 (2007) 335-338
43. Finger P.T. Radiation retinopathy is treatable with anti-vascular endothelial growth factor bevacizumab (Avastin). Int J Radiat Oncol Biol Phys 70 (2008) 974-977
44. Trotti A., Colevas A.D., Setser A., et al. CTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatment. Semin Radiat Oncol 13 (2003) 176-181
45. Trotti A., Byhardt R., Stetz J., et al. Common toxicity criteria: Version 2.0. an improved reference for grading the acute effects of cancer treatment: Impact on radiotherapy. Int J Radiat Oncol Biol Phys 47 (2000) 13-47
46. Cox J.D., Stetz J., and Pajak T.F. Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC). Int J Radiat Oncol Biol Phys 31 (1995) 1341-1346
47. Lee M., Kalani M.Y., Cheshier S., et al. Radiation therapy and CyberKnife radiosurgery in the management of craniopharyngiomas. Neurosurg Focus 24 (2008) E4
48. Pigeaud-Klessens M.L., and Kralendonk J.H. Radiation retino- and opticopathy: A prospective study. Doc Ophthalmol 79 (1992) 285-291